Spectrum Pharmaceuticals, Inc.
Symbol: SPPI
NASDAQ
1.03
USDMarktpreis heute
-5.7473
P/E-Verhältnis
-0.0806
PEG-Verhältnis
211.40M
MRK Kapital
- 0.00%
DIV Rendite
Spectrum Pharmaceuticals, Inc. (SPPI) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 299.44 | 75.1 | 100.6 | 180 | |||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 124.94 | 34.7 | 12.1 | 134 | |||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 48.45 | 13.6 | 1 | 2.5 | |||||||||||||||||||||||||||
balance-sheet.row.inventory | 31.46 | 9.2 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 13.6 | 3.1 | 2.3 | 4.2 | |||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 392.95 | 101 | 104 | 186.6 | |||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 8.56 | 2.2 | 3 | 5.8 | |||||||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 5.97 | 6 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 1.89 | -5.8 | 4.6 | 4.3 | |||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 16.42 | 2.3 | 7.6 | 10.2 | |||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.total-assets | 409.37 | 103.3 | 111.5 | 196.8 | |||||||||||||||||||||||||||
balance-sheet.row.account-payables | 148.62 | 38.1 | 41.3 | 43.8 | |||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 3 | 0.8 | 1.3 | 1.5 | |||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 2.7 | 2.7 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 85.99 | 28.7 | 0 | 0 | |||||||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 20.61 | 3.8 | 10.7 | 7.8 | |||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 113.15 | 32.8 | 10.8 | 9.4 | |||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 3 | 0.8 | 1.3 | 1.5 | |||||||||||||||||||||||||||
balance-sheet.row.total-liab | 285.38 | 75.5 | 64 | 62.6 | |||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.common-stock | 0.8 | 0.2 | 0.2 | 0.1 | |||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | -4442.41 | -1119.3 | -1043.9 | -885.3 | |||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -11.77 | -2.9 | -3 | -1.8 | |||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 4577.36 | 1149.9 | 1094.4 | 1021.2 | |||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 123.99 | 27.9 | 47.6 | 134.2 | |||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 409.37 | 103.3 | 111.5 | 196.8 | |||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.total-equity | 123.99 | 27.9 | 47.6 | 134.2 | |||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 409.37 | - | - | - | |||||||||||||||||||||||||||
Total Investments | 124.94 | 34.7 | 12.1 | 134 | |||||||||||||||||||||||||||
balance-sheet.row.total-debt | 88.22 | 29.4 | 1.3 | 1.5 | |||||||||||||||||||||||||||
balance-sheet.row.net-debt | -86.29 | -10.9 | -87.3 | -44.5 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -64.97 | -75.4 | -158.6 | -160.9 | |||||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0.22 | 0.2 | 0.3 | 0.3 | |||||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 14.7 | 4 | |||||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 7.26 | 8.5 | 19.8 | 17.8 | |||||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | -33.75 | -35.2 | 2.6 | -12.5 | |||||||||||||||||||||||||||
cash-flows.row.account-receivables | -32.76 | -13 | 0.1 | 0 | |||||||||||||||||||||||||||
cash-flows.row.inventory | -3.49 | -9.2 | 0 | 0 | |||||||||||||||||||||||||||
cash-flows.row.account-payables | 13.73 | -3.7 | -3.5 | -22.1 | |||||||||||||||||||||||||||
cash-flows.row.other-working-capital | 6.94 | -9.3 | 6.1 | 9.5 | |||||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 3.1 | 4.9 | 1.6 | 29.7 | |||||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -88.13 | 0 | 0 | 0 | |||||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.34 | -0.3 | -0.2 | -5.5 | |||||||||||||||||||||||||||
cash-flows.row.acquisitions-net | -0.25 | -2.2 | 6 | -4 | |||||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -34.15 | -34.6 | -16.9 | -89.4 | |||||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 38.67 | 8.1 | 125.8 | 113 | |||||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0.25 | 2.2 | -6 | 4 | |||||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 4.18 | -26.7 | 108.7 | 18.1 | |||||||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 28.36 | 46.6 | 52.6 | 84.6 | |||||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 29.34 | 29 | 0.7 | 0.7 | |||||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 57.7 | 75.6 | 53.3 | 85.2 | |||||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.06 | -0.1 | 0 | -0.1 | |||||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | -26.31 | -48.2 | 42.5 | -18.4 | |||||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 174.51 | 40.4 | 88.5 | 46 | |||||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 200.81 | 88.5 | 46 | 64.4 | |||||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | -88.13 | -97 | -119.5 | -121.6 | |||||||||||||||||||||||||||
cash-flows.row.capital-expenditure | -0.34 | -0.3 | -0.2 | -5.5 | |||||||||||||||||||||||||||
cash-flows.row.free-cash-flow | -88.47 | -97.3 | -119.7 | -127.2 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 25.77 | 10.1 | 0 | 0 | |||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 2.9 | 1.8 | 0 | 0 | |||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 22.87 | 8.3 | 0 | 0 | |||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
income-statement-row.row.research-development | 43.44 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.other-expenses | -3.75 | -5.3 | -10.9 | -2.9 | |||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 86.38 | 81 | 147.7 | 169.7 | |||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 89.23 | 82.8 | 147.7 | 169.7 | |||||||||||||||||||||||||||
income-statement-row.row.interest-income | 1.42 | 1 | 0.2 | 1.3 | |||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 2.09 | 1 | 0 | 0 | |||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -4.17 | -5.4 | -10.7 | -1.6 | |||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -3.75 | -5.3 | -10.9 | -2.9 | |||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -4.17 | -5.4 | -10.7 | -1.6 | |||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 2.09 | 1 | 0 | 0 | |||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 1.75 | -4.4 | 0.3 | 0.3 | |||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | -61.88 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.operating-income | -63.51 | -72.7 | -147.7 | -169.7 | |||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | -67.68 | -78.1 | -158.4 | -171.3 | |||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | -2.62 | 0 | 0 | -0.1 | |||||||||||||||||||||||||||
income-statement-row.row.net-income | -65.06 | -78.1 | -158.4 | -171.3 |
Häufig gestellte Frage
Wie hoch ist die Spectrum Pharmaceuticals, Inc. (SPPI) Gesamtvermögen?
Spectrum Pharmaceuticals, Inc. (SPPI) Gesamtvermögen ist 103338000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist 25729000.000.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.889.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -0.322.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist -1.400.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist -1.481.
Was ist der Spectrum Pharmaceuticals, Inc. (SPPI) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -78104000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 29427000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 81019000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 52373000.000.